Stock CRYSTALGENOMICS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company CrystalGenomics Inc. Korea S.E.

Equities

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
- - Intraday chart for CrystalGenomics Inc.
Mar. 27 PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd. CI
Mar. 18 PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd. CI

Business Summary

CrystalGenomics Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates through three segments. The fFinished Pharmaceuticals Manufacturing segment is engaged in the manufacture and sale of finished pharmaceuticals. The Pharmaceutical R&D Division is engaged in the provision of clinical trial analysis and technical services and the sale of new drugs. The segment also operates in the real estate leasing business. The Others segment engages in the manufacture and sale of hot fats and other household items.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Drug Research and Development
374.5 %
17,606 45.6 % 18,272 374.5 % +3.78%
Inter-sectoral Adjustment
-292.2 %
-14,455 -37.4 % -14,256 -292.2 % -1.37%
Investment
17.7 %
598 1.5 % 863 17.7 % +44.37%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
87.8 %
38,564 99.8 % 4,281 87.8 % -88.90%
Overseas
12.2 %
78 0.2 % 597 12.2 % +667.42%

Managers

Managers TitleAgeSince
Joong-Myung Cho CEO
 Chief Executive Officer 75 99-12-31
Young-Joon Yoo AUD
 Comptroller/Controller/Auditor 52 -

Members of the board

Members of the board TitleAgeSince
Joong-Myung Cho CEO
 Chief Executive Officer 75 99-12-31
Jin-Woo Lee BRD
 Director/Board Member 59 17-03-30
Kyung-Sook Cho BRD
 Director/Board Member 64 -
Seung-Soo Shin BRD
 Director/Board Member 52 -
Jin-Gon Kim BRD
 Director/Board Member 60 -
Si-Young Song BRD
 Director/Board Member 66 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 15,000,000 0 0 77.42 %
Stock B 0 4,382,470 0 0
Stock C 1 76,894,182 59,530,603 ( 77.42 %) 350,739 ( 0.4561 %)

Shareholders

NameEquities%Valuation
New Lake Investments Ltd.
34.92 %
26,850,089 34.92 % 75 M
KUMHO HT, INC.
7.326 %
5,633,000 7.326 % 16 M
Joong-Myung Cho
4.230 %
3,252,838 4.230 % 9 M
CRYSTALGENOMICS INVITES CO., LTD.
2.392 %
1,839,483 2.392 % 5 M
OSUNG ADVANCED MATERIALS CO., LTD.
1.951 %
1,500,000 1.951 % 4 M
Sang-Chun Ahn
0.9190 %
706,651 0.9190 % 2 M
Sang-geum Ahn
0.1601 %
123,142 0.1601 % 343 015
In-Chul Chung
0.1425 %
109,595 0.1425 % 305 279
Crystalgenomics, Inc. Employee Stock Ownership Assn.
0.0816 %
62,751 0.0816 % 174 794
Seung-Soo Shin
0.0520 %
40,000 0.0520 % 111 421

Holdings

NameEquities%Valuation
HWAIL PHARMACEUTICAL CO.,LTD.
11.41%
 7,591,240 11.41% 9,315,287 $
PANGEN BIOTECH INC.
17.83%
 1,903,405 17.83% 8,850,738 $
CRYSTALGENOMICS INVITES CO., LTD.
2.39%
 1,839,483 2.39% 5,123,917 $

Company contact information

CrystalGenomics Invites Co., Ltd.

5/F, Tower A, Korea Bio Park 700 Daewangpangyo-ro

13488, Seongnam-si

+

http://www.crystalgenomics.com
address CrystalGenomics Inc.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.75% 659B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.13% 557B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.01% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.77% 322B
ABBVIE INC. Stock AbbVie Inc.
+9.54% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.00% 215B
NOVARTIS AG Stock Novartis AG
+5.34% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.05% 200B
PFIZER, INC. Stock Pfizer, Inc.
-8.46% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A083790 Stock
  4. Stock
  5. Company CrystalGenomics Inc.